These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2426678)

  • 21. [Ventricular tachycardia].
    Adinolfi L; Bonaduce D; Dote I; Golia B; Masullo LA; Chiariello M
    Minerva Med; 1985 Nov; 76(44):2101-9. PubMed ID: 4069422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
    Waleffe A; Mary-Rabine L; Legrand V; Demoulin JC; Kulbertus HE
    Am Heart J; 1980 Dec; 100(6 Pt 1):788-93. PubMed ID: 7446381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
    Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
    J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
    Toivonen L; Kadish A; Morady F
    Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy.
    Heger JJ; Hubbard J; Zipes DP; Miles WM; Prystowsky EN
    Am J Cardiol; 1984 Nov; 54(9):40D-44D. PubMed ID: 6496368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-activated transvenous cardiac stimulation for the treatment of supraventricular and ventricular tachycardia.
    Hartzler GO; Holmes DR; Osborn MJ
    Am J Cardiol; 1981 Apr; 47(4):903-9. PubMed ID: 7211706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tachycardias initiated by automatic antitachycardia pacemakers.
    Fåhraeus T; Lassvik C; Sonnhag C
    Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1049-54. PubMed ID: 6209623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias.
    Rosenthal ME; Hamer A; Gang ES; Oseran DS; Mandel WJ; Peter T
    Am Heart J; 1985 Nov; 110(5):970-6. PubMed ID: 4061272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propafenone: noninvasive evaluation of efficacy.
    Podrid PJ; Cytryn R; Lown B
    Am J Cardiol; 1984 Nov; 54(9):53D-59D. PubMed ID: 6496369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation.
    Podczeck A; Frohner K; Hief C; Stix G; Steinbach KK
    Eur Heart J; 1991 Jul; 12(7):796-9. PubMed ID: 1889445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid ventricular pacing to control resistant neonatal atrioventricular re-entrant tachycardias.
    Ward DE; Rigby M; Dawson P; Collins M; Shinebourne EA
    Pediatr Cardiol; 1984; 5(1):45-8. PubMed ID: 6462928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing.
    Morady F; Shen E; Schwartz A; Hess D; Bhandari A; Sung RJ; Scheinman MM
    J Am Coll Cardiol; 1983 Dec; 2(6):1053-9. PubMed ID: 6630777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
    Gomes JA; Hariman RJ; Kang PS; Chowdry IH
    J Am Coll Cardiol; 1985 Jan; 5(1):45-57. PubMed ID: 3964808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia.
    Josephson ME; Horowitz LN
    Am J Cardiol; 1979 Mar; 43(3):631-42. PubMed ID: 369349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How and why treat supraventricular tachycardias].
    Kulbertus H
    G Ital Cardiol; 1984 Apr; 14(4):269-72. PubMed ID: 6735019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.
    Karagueuzian HS; Fujimoto T; Katoh T; Peter T; McCullen A; Mandel WJ
    Circulation; 1982 Dec; 66(6):1190-8. PubMed ID: 7139897
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
    Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Termination of ventricular tachycardia by noninvasive methods].
    Occhetta E; Piccinino C; Perucca A; Magnani A; Rognoni G; Rossi P
    Minerva Cardioangiol; 1991 Jun; 39(6):239-44. PubMed ID: 1961443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.